Cambria Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Cambria Investment Management's LLY Position: Q2 2026 in Review
Cambria Investment Management increased its Eli Lilly (LLY) stake by 96% in Q2 2026, buying an estimated $2.09M and bringing the position to 4,161 shares worth $4.99M. The position accounts for 0.25% of the portfolio, ranked #142.
Cambria Investment Management first reported a position in LLY in Q4 2014 and has held it in 18 quarters since. The position peaked at $5.95M in Q4 2017. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Cambria Investment Management held 4,161 shares of Eli Lilly worth $4.99M as of Q2 2026.
- Cambria Investment Management bought 2,041 Eli Lilly shares in Q2 2026, an estimated $2.09M.
- Eli Lilly made up 0.25% of Cambria Investment Management's portfolio in Q2 2026, its #142 holding.
- Cambria Investment Management first reported a position in Eli Lilly in Q4 2014 and has held it in 18 quarters since.
- Cambria Investment Management's Eli Lilly position peaked at $5.95M in Q4 2017.
- 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Cambria Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.